# MAGI1

## Overview
MAGI1 is a gene that encodes the protein membrane-associated guanylate kinase, WW and PDZ domain containing 1, which is a member of the membrane-associated guanylate kinase (MAGUK) family. This protein functions primarily as a scaffold protein, playing a pivotal role in maintaining cell-cell adhesion and polarity, which are crucial for tissue integrity and function. MAGI1 is characterized by its unique domain structure, including six PDZ domains, two WW domains, and a guanylate kinase-like domain, which facilitate its interactions with various proteins involved in cell signaling and structural maintenance. The protein is localized at tight and adherens junctions in epithelial cells, where it interacts with other proteins to regulate signaling pathways and cellular differentiation. Additionally, MAGI1 is involved in synaptic localization and ion channel regulation in the nervous system, highlighting its diverse roles across different tissues (Wörthmüller2021MAGI1; Sakurai2006MAGI-1; Kotelevets2021A).

## Structure
MAGI1 is a member of the membrane-associated guanylate kinase (MAGUK) family, characterized by a unique arrangement of domains. It contains six PDZ domains, two WW domains, and one guanylate kinase-like (GUK) domain, with the GUK domain located at the NH2 terminus, followed by the WW and PDZ domains in an inverted arrangement compared to other MAGUKs (Xu2008MAGI-1; Kotelevets2021A). The PDZ domains, approximately 80-90 amino acids in length, form a two α-helical/six β-strand structure and are involved in anchoring cell surface receptors and cell adhesion molecules to the actin cytoskeleton (Kotelevets2021A).

MAGI1 exists in several isoforms, such as MAGI1A, B, and C, resulting from alternative splicing downstream of the sequence encoding PDZ5. These isoforms have unique C termini, with MAGI1C containing potential nuclear targeting signals (Kotelevets2021A). Posttranscriptional modifications, including an in-frame insertion of 28 amino-acid residues upstream of the PDZ3 domain, contribute to the diversity of MAGI1 (Kotelevets2021A).

The protein's structure is further defined by its interaction capabilities, as the PDZ domains selectively bind to the C-terminus of partner proteins, playing a critical role in cellular processes such as cell-cell interaction and signal transduction (Kotelevets2021A).

## Function
MAGI1, a member of the membrane-associated guanylate kinase (MAGUK) family, functions as a scaffold protein involved in various cellular processes. It plays a critical role in maintaining cell-cell adhesion and polarity, essential for tissue integrity and function. MAGI1 is localized at tight junctions and adherens junctions in epithelial cells, where it interacts with proteins such as ZO-1, JAM4, and ESAM to regulate cell signaling pathways, gene expression, and cell differentiation (Wörthmüller2021MAGI1). In vascular endothelial cells, MAGI1 is crucial for the activation of Rap1, a small GTPase, upon cell-cell contact, enhancing VE-cadherin-mediated cell adhesion and maintaining vascular integrity (Sakurai2006MAGI-1).

MAGI1 also interacts with the PTEN tumor suppressor, stabilizing adherens junctions and suppressing invasiveness in epithelial cells by modulating signaling pathways such as PI3K/AKT and Wnt/β-catenin (Wörthmüller2021MAGI1). In the nervous system, MAGI1 is involved in synaptic localization and ion channel homeostasis, interacting with potassium channels and regulating the surface expression of GLT1 in the hippocampus (Wörthmüller2021MAGI1). These interactions highlight MAGI1's role in maintaining cellular structure and function across various tissues.

## Clinical Significance
MAGI1 is implicated in various cancers, where its downregulation or loss is associated with increased tumor aggressiveness and poor prognosis. In breast cancer, particularly estrogen receptor-positive (ER+) types, low MAGI1 levels correlate with resistance to endocrine therapy and a more aggressive phenotype. This is linked to impaired DNA repair and activation of the PI3K/AKT and MAPK signaling pathways, contributing to tumor progression and drug resistance (Kotelevets2021A; Wörthmüller2023MAGI1). In colorectal cancer, MAGI1 acts as a tumor suppressor by inhibiting the Wnt/β-catenin signaling pathway, and its expression is increased by COX-2 inhibitors, which have anti-cancer effects (Zaric2011Identification).

In cervical cancer, particularly with HPV 16 integration, MAGI1 loss is linked to increased proliferation, invasiveness, and metastasis, suggesting its role as a tumor suppressor and potential biomarker for tumor progression (CatalánCastorena2024Bioinformatics). MAGI1 is also involved in maintaining epithelial barrier integrity, and its disruption can lead to increased intestinal permeability and inflammation, potentially contributing to colorectal cancer (Kotelevets2021A). In gliomas, MAGI1 expression is negatively correlated with tumor grade, indicating its role in suppressing tumor progression (Kotelevets2021A).

## Interactions
MAGI1 is a scaffolding protein that participates in various protein-protein interactions, playing a crucial role in cell signaling and maintaining cell junctions. It interacts with actin-binding proteins such as synaptopodin and α-actinin-4. Synaptopodin binds to the WW domains of MAGI1, specifically the second WW domain, as demonstrated by in vitro and in vivo binding assays (Patrie2002Interaction). α-Actinin-4 interacts with the fifth PDZ domain of MAGI1, facilitating a connection to the actin cytoskeleton (Patrie2002Interaction).

MAGI1 also interacts with proteins involved in cell adhesion and signaling. It binds to β-catenin through its PDZ5 domain, which is essential for its localization to cell-cell contacts and for the activation of Rap1, a small GTPase involved in cell adhesion (Sakurai2006MAGI-1). MAGI1 is known to associate with the endothelial adhesion molecule ESAM, recruiting it to intercellular contacts in a PDZ domain-dependent manner (Wegmann2004Endothelial). These interactions highlight MAGI1's role in forming multiprotein complexes and linking membrane-associated proteins to the cytoskeleton, thereby influencing cellular architecture and function.


## References


[1. (CatalánCastorena2024Bioinformatics) Oscar Catalán-Castorena, Olga Lilia Garibay-Cerdenares, Berenice Illades-Aguiar, Rocio Castillo-Sánchez, Ma. Isabel Zubillaga-Guerrero, Marco Antonio Leyva-Vazquez, Sergio Encarnacion-Guevara, Eugenia Flores-Alfaro, Mónica Ramirez-Ruano, and Luz del Carmen Alarcón-Romero. Bioinformatics analysis of human papillomavirus 16 integration in cervical cancer: changes in magi-1 expression in premalignant lesions and invasive carcinoma. Cancers, 16(12):2225, June 2024. URL: http://dx.doi.org/10.3390/cancers16122225, doi:10.3390/cancers16122225. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers16122225)

[2. (Wegmann2004Endothelial) Frank Wegmann, Klaus Ebnet, Louis Du Pasquier, Dietmar Vestweber, and Stefan Butz. Endothelial adhesion molecule esam binds directly to the multidomain adaptor magi-1 and recruits it to cell contacts. Experimental Cell Research, 300(1):121–133, October 2004. URL: http://dx.doi.org/10.1016/j.yexcr.2004.07.010, doi:10.1016/j.yexcr.2004.07.010. This article has 68 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2004.07.010)

[3. (Wörthmüller2023MAGI1) Janine Wörthmüller, Simona Disler, Sylvain Pradervand, François Richard, Lisa Haerri, Gustavo A. Ruiz Buendía, Nadine Fournier, Christine Desmedt, and Curzio Rüegg. Magi1 prevents senescence and promotes the dna damage response in er+ breast cancer. Cells, 12(15):1929, July 2023. URL: http://dx.doi.org/10.3390/cells12151929, doi:10.3390/cells12151929. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells12151929)

[4. (Xu2008MAGI-1) Zhigang Xu, Anthony W. Peng, Kazuo Oshima, and Stefan Heller. Magi-1, a candidate stereociliary scaffolding protein, associates with the tip-link component cadherin 23. The Journal of Neuroscience, 28(44):11269–11276, October 2008. URL: http://dx.doi.org/10.1523/jneurosci.3833-08.2008, doi:10.1523/jneurosci.3833-08.2008. This article has 64 citations.](https://doi.org/10.1523/jneurosci.3833-08.2008)

[5. (Patrie2002Interaction) Kevin M. Patrie, Andrew J. Drescher, Ajith Welihinda, Peter Mundel, and Ben Margolis. Interaction of two actin-binding proteins, synaptopodin and α-actinin-4, with the tight junction protein magi-1. Journal of Biological Chemistry, 277(33):30183–30190, August 2002. URL: http://dx.doi.org/10.1074/jbc.m203072200, doi:10.1074/jbc.m203072200. This article has 111 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m203072200)

[6. (Wörthmüller2021MAGI1) Janine Wörthmüller and Curzio Rüegg. Magi1, a scaffold protein with tumor suppressive and vascular functions. Cells, 10(6):1494, June 2021. URL: http://dx.doi.org/10.3390/cells10061494, doi:10.3390/cells10061494. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells10061494)

[7. (Kotelevets2021A) Larissa Kotelevets and Eric Chastre. A new story of the three magi: scaffolding proteins and lncrna suppressors of cancer. Cancers, 13(17):4264, August 2021. URL: http://dx.doi.org/10.3390/cancers13174264, doi:10.3390/cancers13174264. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13174264)

[8. (Zaric2011Identification) J Zaric, J-M Joseph, S Tercier, T Sengstag, L Ponsonnet, M Delorenzi, and C Rüegg. Identification of magi1 as a tumor-suppressor protein induced by cyclooxygenase-2 inhibitors in colorectal cancer cells. Oncogene, 31(1):48–59, June 2011. URL: http://dx.doi.org/10.1038/onc.2011.218, doi:10.1038/onc.2011.218. This article has 48 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2011.218)

[9. (Sakurai2006MAGI-1) Atsuko Sakurai, Shigetomo Fukuhara, Akiko Yamagishi, Keisuke Sako, Yuji Kamioka, Michitaka Masuda, Yoshikazu Nakaoka, and Naoki Mochizuki. Magi-1 is required for rap1 activation upon cell-cell contact and for enhancement of vascular endothelial cadherin-mediated cell adhesion. Molecular Biology of the Cell, 17(2):966–976, February 2006. URL: http://dx.doi.org/10.1091/mbc.e05-07-0647, doi:10.1091/mbc.e05-07-0647. This article has 127 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e05-07-0647)